Humana stock tumbles in premarket after CMS flags near-flat 2027 Medicare Advantage rates
Humana shares fell about 12% in premarket trading Tuesday after a U.S. proposal signaled minimal Medicare Advantage payment growth for 2027. The Centers for Medicare & Medicaid Services set a net average increase of 0.09%, citing risk score changes and new limits on chart review diagnoses. UnitedHealth and CVS Health also dropped around 9%. Investors await the April 6 final rate notice.
